Rubella notifications and confirmed cases by oral fluid testing 2013 to 2022 by quarter
Updated 21 September 2022
Applies to England and Wales
© Crown copyright 2022
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/rubella-confirmed-cases/rubella-notifications-and-confirmed-cases-by-oral-fluid-testing-in-england-2013-to-2014-by-quarter
Following the Measles-Rubella (MR) school campaign in November 1994 the Public Health England (now UK Health Security Agency) predecessor (PHLS) has offered oral fluid testing to confirm the diagnosis on all notified cases of measles, mumps and rubella. This is part of the enhanced surveillance programme for these vaccine-preventable diseases.
The table below shows only the cases confirmed by oral fluid IgM antibody tests and/or PCR in each quarter compared to the number of notified cases.
| Year | Quarter | Uncorrected notified cases | Number tested | % | Number positive | % | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | 2* | 30 | 22 | 73.3% | 0 | 0.0% | ||||||
| 2022 | 1 | 28 | 24 | 85.7% | 0 | 0.0% | ||||||
| 2021 | 4 | 21 | 23 | 109.5% | 0 | 0.0% | ||||||
| 2021 | 3 | 15 | 22 | 146.7% | 0 | 0.0% | ||||||
| 2021 | 2 | 19 | 30 | 157.9% | 0 | 0.0% | ||||||
| 2021 | 1 | 12 | 15 | 125.0% | 0 | 0.0% | ||||||
| 2020 | 4 | 8 | 10 | 125.0% | 0 | 0.0% | ||||||
| 2020 | 3 | 16 | 17 | 106.3% | 0 | 0.0% | ||||||
| 2020 | 2 | 14 | 11 | 78.6% | 0 | 0.0% | ||||||
| 2020 | 1 | 84 | 77 | 91.7% | 0 | 0.0% | ||||||
| 2019 | 4 | 59 | 87 | 147.5% | 1 | 1.1% | ||||||
| 2019 | 3 | 35 | 64 | 182.9% | 0 | 0.0% | ||||||
| 2019 | 2 | 54 | 89 | 164.8% | 0 | 0.0% | ||||||
| 2019 | 1 | 75 | 74 | 98.7% | 0 | 0.0% | ||||||
| 2018 | 4 | 60 | 92 | 153.3% | 1 | 1.1% | ||||||
| 2018 | 3 | 45 | 55 | 122.2% | 1 | 1.8% | ||||||
| 2018 | 2 | 84 | 73 | 86.9% | 0 | 0.0% | ||||||
| 2018 | 1 | 95 | 82 | 86.3% | 1 | 0.0% | ||||||
| 2017 | 4 | 82 | 73 | 89.0% | 0 | 0.0% | ||||||
| 2017 | 3 | 68 | 53 | 77.9% | 0 | 0.0% | ||||||
| 2017 | 2 | 98 | 99 | 101.0% | 0 | 0.0% | ||||||
| 2017 | 1 | 114 | 62 | 41.3% | 0 | 0.0% | ||||||
| 2016 | 4 | 85 | 52 | 61.2% | 1 | 1.9% | ||||||
| 2016 | 3 | 65 | 54 | 83.1% | 0 | 0.0% | ||||||
| 2016 | 2 | 87 | 68 | 78.2% | 0 | 0.0% | ||||||
| 2016 | 1 | 106 | 69 | 65.1% | 1 | 0.0% | ||||||
| 2015 | 4 | 95 | 81 | 85.3% | 0 | 0.0% | ||||||
| 2015 | 3 | 91 | 73 | 80.2% | 0 | 0.0% | ||||||
| 2015 | 2 | 107 | 100 | 93.5% | 1 | 0.0% | ||||||
| 2015 | 1 | 105 | 82 | 78.1% | 1 | 0.0% | ||||||
| 2014 | 4 | 104 | 80 | 76.9% | 0 | 0.0% | ||||||
| 2014 | 3 | 99 | 72 | 72.7% | 0 | 0.0% | ||||||
| 2014 | 2 | 137 | 86 | 62.8% | 1 | 1.2% | ||||||
| 2014 | 1 | 124 | 118 | 95.2% | 0 | 0.0% | ||||||
| 2013 | 4 | 88 | 32 | 35.2% | 1 | 3.2% | ||||||
| 2013 | 3 | 110 | 56 | 50.9% | 0 | 0.0% | ||||||
| 2013 | 2 | 188 | 88 | 46.8% | 0 | 0.0% | ||||||
| 2013 | 1 | 181 | 93 | 51.4% | 2 | 2.1% |
*provisional data
Source: Notifications of Infectious Diseases, UK Health Security Agency.
To view data from 1995 to 2012, view the archived health protection website.